Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies
- 15 August 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 44 (2), 208-218
- https://doi.org/10.1002/ijc.2910440204
Abstract
A series of 14 monoclonal anti‐carcinoembryonic antigen (CEA, Mr 180,000) antibodies (MAbs) that show a strong degree of selective reactivity for human colon carcinomas versus normal adult tissues were used to construct a serological map of the CEA molecule. The MAbs were generated using extracts of colon carcinomas as immunogen and are thus given a COL designation. None of the 14 COL‐MAbs tested were reactive with purified non‐specific cross‐reacting antigen (NCA, Mr 55,000) from normal lung, although some showed reactivity to human granulocytes. All the COL‐MAbs tested were reactive with normal fecal antigen‐2 (NFA‐2, Mr170,000); however, many of the COL‐MAbs demonstrated a higher affinity constant to CEA than to NFA‐2. Cross‐competition radioimmunoassays classified the 14 COL‐MAbs into 5 groups. The chemical nature of the COL‐binding domains was tested using chemically or enzymatically treated CEA; all reacted with periodate‐treated CEA and deglycosy‐lated CEA, indicating that the COL‐reactive epitopes appear to be of a proteinaceous nature. Heat treatment, reduction, alkylation, pepsin digestion or pronase treatment of CEA, however, gave differential results with respect to COL binding. Antibody titration experiments were carried out to define differential reactivities to colorectal carcinoma versus NCA‐containing granulocyte extracts; these results were compared with results obtained using several anti‐CEA MAbs that have been used in clinical trials. Granulocyte binding and biochemical studies showed that the COL MAbs may distinguish as many as 7 to 10 CEA epitopes.This publication has 37 references indexed in Scilit:
- Analysis of the specificity of CEA reactive monoclonal antibodies. Immunological support for the domain-model of CEAMolecular Immunology, 1988
- Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytesMolecular Immunology, 1987
- Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequenceBiochemical and Biophysical Research Communications, 1987
- Identification and partial characterization of the unglycosylated peptide of carcinoembryonic antigen synthesized by human tumor cell lines in the presence of tunicamycinMolecular Immunology, 1984
- Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kDInternational Journal of Cancer, 1984
- Immunological characterization and structural studies of normal fecal antigen-1 related to carcinoembryonic antigenMolecular Immunology, 1982
- Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphyImmunology Today, 1981
- Idiotype‐anti‐idiotype interactions and the control of the anti‐β(2→6) polyfructosan response in the mouse: specificity and idiotypy of anti‐ABPC48 anti‐idiotypic monoclonal antibodiesEuropean Journal of Immunology, 1981
- SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEMThe Journal of Experimental Medicine, 1965